Anti-RIMKLA Antibody Picoband® fluoro594 Vervoeging

Predicted to enable N-acetyl-L-aspartate-L-glutamate ligase activity. Predicted to be involved in glutamine family amino acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.

Solute carrier family 2, facilitated glucose transporter member 6; Glucose transporter type 6; GLUT-6; Glucose transporter type 9; GLUT-9; SLC2A6; GLUT9

RIMKLA

284716

Q8IXN7

Human

No cross-reactivity with other proteins.

E.coli-derived human RIMKLA recombinant protein (Position: Q19-K391) .

Highly expressed in brain, spleen and peripheral blood leukocytes.

Flow Cytometry

Cancer, Channels, Metabolism, Plasma Membrane, Signal Transduction

Immunogen affinity purified.

Liquid

Facilitative glucose transporter; binds cytochalasin B with low affinity.

1. Collard, F., Stroobant, V., Lamosa, P., Kapanda, C. N., Lambert, D. M., Muccioli, G. G., Poupaert, J. H., Opperdoes, F., Van Schaftingen, E. Molecular identification of N-acetylaspartylglutamate synthase and beta-citrylglutamate synthase. J. Biol. Chem. 285: 29826-29833, 2010. 2. Gross, M. B. Personal Communication. Baltimore, Md. 7/13/2020. 3. Lodder-Gadaczek, J., Becker, I., Gieselmann, V., Wang-Eckhardt, L., Eckhardt, M. N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate. J. Biol. Chem. 286: 16693-16706, 2011.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

6

Solute carrier family 2 member 6

Cell membrane. Multi-pass membrane protein.

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.